SIONNA THERAPEUTICS Trademark

Trademark Overview

On Friday, July 16, 2021, a trademark application was filed for SIONNA THERAPEUTICS with the United States Patent and Trademark Office. The USPTO has given the SIONNA THERAPEUTICS trademark a serial number of 90833921. The federal status of this trademark filing is STATEMENT OF USE - TO EXAMINER as of Saturday, July 26, 2025. This trademark is owned by Sling Therapeutics, Inc.. The SIONNA THERAPEUTICS trademark is filed in the Pharmaceutical Products and Computer & Software Services & Scientific Services categories with the following description:

Pharmaceutical preparations for the treatment of pulmonary diseases and rare diseases

Pharmaceutical research and development
sionna therapeutics

General Information

Serial Number90833921
Word MarkSIONNA THERAPEUTICS
Filing DateFriday, July 16, 2021
Status748 - STATEMENT OF USE - TO EXAMINER
Status DateSaturday, July 26, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, June 7, 2022

Trademark Statements

Goods and ServicesPharmaceutical preparations for the treatment of pulmonary diseases and rare diseases
NOT AVAILABLE"THERAPEUTICS"
Goods and ServicesPharmaceutical research and development

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, September 20, 2021
Primary Code005
First Use Anywhere DateMonday, October 31, 2022
First Use In Commerce DateMonday, October 31, 2022
International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateMonday, September 20, 2021
Primary Code042
First Use Anywhere DateSunday, June 30, 2024
First Use In Commerce DateSunday, June 30, 2024

Trademark Owner History

Party NameSIONNA THERAPEUTICS, INC.
Party Type21 - New Owner After Publication
Legal Entity Type03 - Corporation
AddressWaltham, MA 02451
Party NameSling Therapeutics, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressNatick, MA 01760
Party NameSling Therapeutics, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressNatick, MA 01760

Trademark Events

Event DateEvent Description
Tuesday, July 20, 2021NEW APPLICATION ENTERED
Wednesday, April 6, 2022ASSIGNED TO EXAMINER
Monday, September 20, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, January 31, 2023SOU TEAS EXTENSION RECEIVED
Tuesday, April 12, 2022EXAMINERS AMENDMENT -WRITTEN
Tuesday, April 12, 2022EXAMINERS AMENDMENT E-MAILED
Tuesday, April 12, 2022NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Tuesday, April 12, 2022EXAMINER'S AMENDMENT ENTERED
Tuesday, May 3, 2022APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, May 18, 2022NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, June 7, 2022PUBLISHED FOR OPPOSITION
Tuesday, June 7, 2022OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, August 2, 2022NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, January 31, 2023SOU EXTENSION 1 FILED
Wednesday, February 15, 2023SOU EXTENSION 1 GRANTED
Thursday, February 16, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, January 26, 2024SOU TEAS EXTENSION RECEIVED
Wednesday, February 15, 2023CASE ASSIGNED TO INTENT TO USE PARALEGAL
Wednesday, February 15, 2023AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Tuesday, July 25, 2023SOU TEAS EXTENSION RECEIVED
Tuesday, July 25, 2023SOU EXTENSION 2 FILED
Tuesday, July 25, 2023SOU EXTENSION 2 GRANTED
Thursday, July 27, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, January 26, 2024SOU EXTENSION 3 FILED
Tuesday, July 2, 2024SOU TEAS EXTENSION RECEIVED
Tuesday, July 2, 2024SOU EXTENSION 4 FILED
Friday, January 26, 2024SOU EXTENSION 3 GRANTED
Tuesday, January 30, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, July 2, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, January 24, 2025SOU EXTENSION 5 FILED
Tuesday, January 28, 2025SOU EXTENSION 5 GRANTED
Tuesday, July 2, 2024SOU EXTENSION 4 GRANTED
Friday, January 24, 2025SOU TEAS EXTENSION RECEIVED
Thursday, July 24, 2025USE AMENDMENT FILED
Thursday, July 24, 2025TEAS STATEMENT OF USE RECEIVED
Saturday, July 26, 2025STATEMENT OF USE PROCESSING COMPLETE
Wednesday, January 29, 2025NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

Related Keywords

therapeutics sionna diseases pharmaceutical research development rare pulmonary preparations treatment